| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |